BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191106
DTEND;VALUE=DATE:20191109
DTSTAMP:20260729T154743
CREATED:20190403T151519Z
LAST-MODIFIED:20190406T180434Z
UID:21161-1572998400-1573257599@ces.b2sg.org
SUMMARY:Epigenomics of Common Diseases
DESCRIPTION:Discussing the future of epigenomic studies of common diseases\nWe are pleased to announce the 8th Epigenomics of Common Diseases conference and invite scientists working on experimental and computational epigenomics and epigenetics to showcase the latest developments in the field and discuss epigenomic approaches in common human diseases. \nEpigenetic variation plays an important role in disease processes and provides a promising focus for disease prediction\, prevention and treatment. Technological advancements in the past few years have fuelled a dramatic increase in the scale\, breadth and availability of epigenomic reference maps\, including populational and environmental epigenomic datasets. \nThis year’s conference will cover a broad spectrum of epigenomic discoveries\, opportunities\, and also challenges\, in human normal biology and in disease. \nProgramme:  \nThe conference will start at 12.30 on Wednesday\, 6 November and close at 14.00 on Friday\, 8 November 2019. \nTopics will include: \n\nGenetic-epigenetic interactions\nOld and new roles of epigenomic factors\nEpigenomics in development and ageing\nEpigenomic misregulation in cancer\, brain and other diseases\nPopulational and environmental epigenomics\nMethodological challenges: epigenomic study design\, data analysis and interpretation\nThe future of epigenomic studies of common diseases\n\n  \nKeynote speakers \nCheryl Arrowsmith – University of Toronto\, Canada \nJohn Stamatoyannopoulos – University of Washington\, USA \n  \nConfirmed speakers \nDeborah Bourc’his – Institut Curie\, France \nJoseph Costello – UC San Francisco\, USA \nJohn Greally – Albert Einstein College of Medicine\, USA \nEilis Hannon – University of Exeter\, UK \nKristian Helin – Sloan Kettering Institute\, USA \nEva Jablonka – Tel Aviv University\, Israel \nViviane Labrie – Van Andel Institute\, USA \nStephanie London – NIEHS\, USA \nMathieu Lupien – University of Toronto\, Canada \nRaphäel Margueron – Institut Curie\, France \nKyung-Min Noh – EMBL\, Germany \nVardhman Rakyan – Queen Mary University of London\, UK \nClaire Rougeulle – CNRS / Université Paris Diderot\, France \nRichard Saffery – Murdoch Children’s Research Institute\, Australia
URL:https://ces.b2sg.org/event/6-8nov19-epigenomics/
LOCATION:Wellcome Genome Campus\, UK\, Wellcome Trust Genome Campus\, Hinxton\, CB10 1SA\, United Kingdom
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2019/04/ECD_EarlyBird_Twitter.jpg
ORGANIZER;CN="Advanced%20Courses%20and%20Scientific%20Conferences%2C%20Wellcome%20Genome%20Campus":MAILTO:scientificconferences@wellcomegenomecampus.org
END:VEVENT
END:VCALENDAR